{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:34:08Z","timestamp":1780338848950,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.msard.2024.105676","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:52:51Z","timestamp":1715442771000},"page":"105676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Exploring suicidal ideation prevalence in multiple sclerosis patients during the COVID-19 pandemic: A study on the relationship between drug use and suicidal ideation"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4943-8559","authenticated-orcid":false,"given":"Shiva","family":"Pouradeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Khadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Rezaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6088-6120","authenticated-orcid":false,"given":"Hossein Ali Ebrahimi","family":"Meimand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0004","first-page":"16","article-title":"Updated systematic review on epidemiology of multiple sclerosis in Iran: central accumulation and possible role for industrial pollution","volume":"1","author":"Abtahi","year":"2021","journal-title":"J. Rev. Med. Sci."},{"key":"10.1016\/j.msard.2024.105676_bib0008","doi-asserted-by":"crossref","unstructured":"Altieri M., Capuano R., Bisecco A., d'Ambrosio A., Buonanno D., Tedeschi G., et al. The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: a meta-analysis. 2022;61:103774.","DOI":"10.1016\/j.msard.2022.103774"},{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0026","first-page":"33","article-title":"Validity and reliability of Beck suicide scale ideation among soldiers","volume":"7","author":"Anisi","year":"2005","journal-title":"J. Mil. Med."},{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0038","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12913-022-07551-z","article-title":"Estimation the medical cost of multiple sclerosis in Iran; 2019\u20132020","volume":"22","author":"Asadollahi","year":"2022","journal-title":"BMC Health Serv. Res."},{"issue":"4","key":"10.1016\/j.msard.2024.105676_bib0027","first-page":"154","article-title":"Predictors of suicidal ideation among Iranian patients with multiple sclerosis","volume":"19","author":"Asgarian","year":"2020","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.msard.2024.105676_bib0030","doi-asserted-by":"crossref","unstructured":"Bhaskar S., Bradley S., Israeli-Korn S., Menon B., Chattu V.K., Thomas P., et al. Chronic neurology in COVID-19 era: clinical considerations and recommendations from the REPROGRAM consortium. 2020;11:664.","DOI":"10.3389\/fneur.2020.00664"},{"key":"10.1016\/j.msard.2024.105676_bib0029","doi-asserted-by":"crossref","unstructured":"Chertcoff A., Bauer J., Silva B.A., Aldecoa M., Eizaguirre M.B., Rodriguez R., et al. Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic. 2021;54:103120.","DOI":"10.1016\/j.msard.2021.103120"},{"key":"10.1016\/j.msard.2024.105676_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103158","article-title":"Association between MS-related knowledge, health literacy, self-efficacy, resilience, and quality of life in a large cohort of MS community members: a cross-sectional study","volume":"54","author":"Claflin","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2024.105676_bib0044","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.msard.2024.105676_bib0048","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jamapsychiatry.2014.2663","article-title":"Suicidal ideation and suicide attempts among adults with psychotic experiences: data from the collaborative psychiatric epidemiology surveys","volume":"72","author":"DeVylder","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.msard.2024.105676_bib0051","doi-asserted-by":"crossref","unstructured":"Dobson R., Rice D.R., D'hooghe M., Horne R., Learmonth Y., Mateen F.J., et al. Social determinants of health in multiple sclerosis. 2022;18(12):723\u201334.","DOI":"10.1038\/s41582-022-00735-5"},{"issue":"4","key":"10.1016\/j.msard.2024.105676_bib0005","first-page":"385","article-title":"Prevalence of multiple sclerosis and environmental factors in Kerman province, Iran","volume":"18","author":"Ebrahimi","year":"2013","journal-title":"Neurol. Asia"},{"key":"10.1016\/j.msard.2024.105676_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.620739","article-title":"Centennials, FOMO, and loneliness: an investigation of the impact of social networking and messaging\/VoIP apps usage during the initial stage of the coronavirus pandemic","volume":"12","author":"Fumagalli","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.msard.2024.105676_bib0019","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.msard.2018.09.008","article-title":"Adverse psychiatric effects of disease-modifying therapies in multiple sclerosis: a systematic review","volume":"26","author":"Gasim","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105676_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103777","article-title":"Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years","volume":"61","author":"Ghadiri","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0037","first-page":"1","article-title":"Iranian specialists\u2019 approach to treatment escalation in multiple sclerosis patients with cognitive impairment","volume":"22","author":"Ghadiri","year":"2023","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.msard.2024.105676_bib0041","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2024.105676_bib0016","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.msard.2024.105676_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1169400","article-title":"The therapeutic value of treatment for multiple sclerosis: analysis of health technology assessments of three European countries","volume":"14","author":"Gozzo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.msard.2024.105676_bib0003","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.msard.2017.12.015","article-title":"Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis","volume":"20","author":"Harirchian","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105676_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.500447","article-title":"PEPSUI, a psychoeducational program for the management of suicidal patients: a qualitative study from a randomized controlled trial","volume":"11","author":"Henrion","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.msard.2024.105676_bib0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jns.2016.03.024","article-title":"Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: an analysis from the EPOC (Evaluate Patient OutComes) trial","volume":"365","author":"Hunter","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0039","first-page":"16","article-title":"Challenges of patients with multiple sclerosis in receiving health care services in Iran","volume":"22","author":"Jahromi","year":"2023","journal-title":"Curr. J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-020-02579-z","article-title":"Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study","volume":"20","author":"Karimi","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.msard.2024.105676_bib0042","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.apmr.2016.04.016","article-title":"Rehabilitation in multiple sclerosis: a systematic review of systematic reviews","volume":"98","author":"Khan","year":"2017","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7224\/1537-2073-14.1.10","article-title":"Depression levels and interferon treatment in people with multiple sclerosis","volume":"14","author":"Kim","year":"2012","journal-title":"Int. J. MS Care"},{"issue":"8","key":"10.1016\/j.msard.2024.105676_bib0012","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/19371918.2020.1810839","article-title":"Prevalence of suicidal ideation in multiple sclerosis patients: meta-analysis of international studies","volume":"35","author":"Kouchaki","year":"2020","journal-title":"Soc. Work Public Health"},{"issue":"9","key":"10.1016\/j.msard.2024.105676_bib0043","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.apmr.2013.04.020","article-title":"Effects of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development","volume":"94","author":"Latimer-Cheung","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.msard.2024.105676_bib0009","doi-asserted-by":"crossref","unstructured":"Lebrasseur A., Fortin-B\u00e9dard N., Lettre J., Bussi\u00e8res E.L., Best K., Boucher N., et al. Impact of COVID-19 on people with physical disabilities: a rapid review. 2021;14(1):101014.","DOI":"10.1016\/j.dhjo.2020.101014"},{"issue":"2","key":"10.1016\/j.msard.2024.105676_bib0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2024.105676_bib0002","doi-asserted-by":"crossref","unstructured":"Nazareth T.A., Rava A.R., Polyakov J.L., Banfe E.N., Waltrip Ii R.W., Zerkowski K.B., et al. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey. 2018;26:219\u201334.","DOI":"10.1016\/j.msard.2018.09.002"},{"key":"10.1016\/j.msard.2024.105676_bib0036","unstructured":"Neurology E. Multiple Sclerosis (MS) treatment 2024 [Available from: https:\/\/norology.com\/."},{"issue":"5","key":"10.1016\/j.msard.2024.105676_bib0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/ane.13148","article-title":"Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran?","volume":"140","author":"Pakdel","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2024.105676_bib0024","doi-asserted-by":"crossref","unstructured":"Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. 2011;69(2):292\u2013302.","DOI":"10.1002\/ana.22366"},{"issue":"12","key":"10.1016\/j.msard.2024.105676_bib0011","doi-asserted-by":"crossref","first-page":"701","DOI":"10.34172\/aim.2023.103","article-title":"Prevalence and risk factors for suicidal ideation following the COVID-19 pandemic in kerman province: a cross-sectional study","volume":"26","author":"Pouradeli","year":"2023","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.msard.2024.105676_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103629","article-title":"The effect of Rituximab on mood disorders in multiple sclerosis","volume":"59","author":"Poursadeghfard","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105676_bib0010","doi-asserted-by":"crossref","unstructured":"Ramezani N., Ashtari F., Bastami E.A., Ghaderi K., Hosseini S.M., Naeini M.K., et al. Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population. 2021;50:102798.","DOI":"10.1016\/j.msard.2021.102798"},{"issue":"6","key":"10.1016\/j.msard.2024.105676_bib0045","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0272989X211058068","article-title":"Shared decision making in health care: theoretical perspectives for why it works and for whom","volume":"42","author":"Resnicow","year":"2022","journal-title":"Med. Decis. Mak."},{"key":"10.1016\/j.msard.2024.105676_bib0034","doi-asserted-by":"crossref","unstructured":"Romaniuc A., B\u0103la\u015fa R., \u015etirbu N., Maier S., Andone S., Bajko Z., et al. The main determinants for suicidal ideation in a romanian cohort of multiple sclerosis patients. 2020;2020.","DOI":"10.1155\/2020\/2594702"},{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0014","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1192\/bjo.2022.615","article-title":"Suicidal ideation among people with disabilities during the COVID-19 pandemic in Bangladesh: prevalence and associated factors","volume":"9","author":"Roy","year":"2023","journal-title":"BJPsych Open"},{"issue":"3","key":"10.1016\/j.msard.2024.105676_bib0025","doi-asserted-by":"crossref","DOI":"10.5812\/jkums.118040","article-title":"Correlation of suicidal thoughts and suicide attempts in patients with multiple sclerosis","volume":"25","author":"Sariaslani","year":"2021","journal-title":"J. Kermanshah Univ. Med. Sci."},{"key":"10.1016\/j.msard.2024.105676_bib0001","first-page":"2351","article-title":"Methods of diagnosis and treatment of MS disease based on a clinical trial: the original article","author":"Seifi","year":"2022","journal-title":"Tob. Regul. Res."},{"key":"10.1016\/j.msard.2024.105676_bib0015","doi-asserted-by":"crossref","unstructured":"Smets I., Holden D., Bianchi L., Ammoscato F., Allen-Philbey K., Baker D., et al. Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: an observational study. 2022;57:103409.","DOI":"10.1016\/j.msard.2021.103409"},{"issue":"2","key":"10.1016\/j.msard.2024.105676_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2020-000108","article-title":"Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study","volume":"3","author":"Smoot","year":"2021","journal-title":"BMJ Neurol. Open"},{"key":"10.1016\/j.msard.2024.105676_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103497","article-title":"Surviving a global pandemic: the experience of depression, anxiety, and loneliness among individuals with multiple sclerosis","volume":"58","author":"Strober","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105676_bib0033","doi-asserted-by":"crossref","unstructured":"Strupp J., Ehmann C., Galushko M., B\u00fccken R., Perrar K.M., Hamacher S., et al. Risk factors for suicidal ideation in patients feeling severely affected by multiple sclerosis. 2016;19(5):523\u20138.","DOI":"10.1089\/jpm.2015.0418"},{"issue":"8","key":"10.1016\/j.msard.2024.105676_bib0013","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.apmr.2006.04.021","article-title":"Suicidal ideation in multiple sclerosis","volume":"87","author":"Turner","year":"2006","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"1","key":"10.1016\/j.msard.2024.105676_bib0018","first-page":"1","article-title":"Depression and anxiety in patients with multiple sclerosis: a retrospective study on the impact of glatiramer acetate","volume":"13","author":"Uca","year":"2011","journal-title":"Int. Arch. Med. Res."},{"key":"10.1016\/j.msard.2024.105676_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104825","article-title":"The psychological impact of the COVID-19 pandemic on people with multiple sclerosis","author":"Vacaras","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105676_bib0046","doi-asserted-by":"crossref","unstructured":"Wei S., Li H., Hou J., Chen W., Tan S., Chen X., et al. Comparing characteristics of suicide attempters with suicidal ideation and those without suicidal ideation treated in the emergency departments of general hospitals in China. 2018;262:78\u201383.","DOI":"10.1016\/j.psychres.2018.02.007"},{"issue":"3","key":"10.1016\/j.msard.2024.105676_bib0047","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10964-009-9487-8","article-title":"Help-negation and suicidal ideation: the role of depression, anxiety and hopelessness","volume":"39","author":"Wilson","year":"2010","journal-title":"J. Youth Adolesc."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T12:07:39Z","timestamp":1720872459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824002530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"alternative-id":["S2211034824002530"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105676","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring suicidal ideation prevalence in multiple sclerosis patients during the COVID-19 pandemic: A study on the relationship between drug use and suicidal ideation","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105676"}}